Doing so could increase the risk of severe side effects or complications
No evidence of severe endocrine, cardiovascular, or hepatic adverse effects has been observed in available research data
For most older adults with obesity, type 2 diabetes, or cardiovascular disease , the benefits are substantial but the potential risks must also be considered: Benefits: cardiovascular protection , significant weight loss , improved glucose control , blood pressure , and inflammation , with a lower risk of hypoglycemia compared to many older therapies
After stopping the medication, participants taking semaglutide regained 11.6% of their body weight, and those taking a placebo regained 1.9%, leading to a net weight loss of 5.6% in the semaglutide group and 0.1% in the placebo group
benefits of GLP-1RAs for your specific situation